PROLOR Biotech, Inc. : PROLOR Biotech Announces Positive Preclinical Results from Comparative Study of its Long-Acting Clotting Factor VIIa – 4-traders (press release)
The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. 07:35a PROLOR Biotech ...
Subscribe to LegalLaw247.Com Newsletter
